Suppr超能文献

阳甘姜莓方通过抑制 NLRP3 炎性小体的自噬来缓解非酒精性脂肪性肝炎。

Yang-Gan-Jiang-Mei formula alleviates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome through mitophagy.

机构信息

The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.

Jiangsu Province Hospital of Chinese Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

出版信息

Biotechnol Genet Eng Rev. 2024 Oct;40(2):1314-1333. doi: 10.1080/02648725.2023.2193482. Epub 2023 Mar 24.

Abstract

As an effective formula of traditional Chinese medicine, Yang-Gan-Jiang-Mei (YGJM) formula exhibited a unique advantage in ameliorating liver injury and hepatic steatosis of non-alcoholic steatohepatitis (NASH). Nevertheless, the related pharmacological mechanism needs to be elucidated. This study aimed to explore the molecular mechanism of YGJM formula on mitophagy mediated by PINK1/parkin signaling pathway and NOD-like receptor protein 3 (NLRP3) inflammasome in NASH. High-fat-diet rats and HepG2 cells induced by free fatty acid were used as NASH models and . Liver pathology and serum indicator embodying liver function (aspartate transferase, alanine transferase, triglyceride, and total cholesterol) were applied to evaluate the extent of hepatic damage and lipid accumulation. Besides, transmission electron microscopy, JC-1 and 2',7'-dichlorofluorescein diacetate were utilized to observe hepatic mitochondrial morphology, as well as cellular mitochondrial membrane potential and reactive oxygen species level. Additionally, expression of PINK1/parkin-mediated mitophagy and NLRP3 inflammasome was detected to elucidate the underlying mechanism of YGJM formula by immunohistochemistry, immunofluorescence, RT-PCR (reverse transcription-polymerase chain reaction) and Western blot. The manifestations of pathology and biochemical detection confirmed the efficacy of YGJM formula in relieving hepatic damage and lipid deposition. Simultaneously, YGJM formula could obviously improve mitochondrial function. In addition, YGJM formula exhibited the promotion of PINK1/parkin-mediated mitophagy, which could perturb NLRP3 inflammasome activation, and as a result, the hepatocyte inflammation was also suppressed both and . Our preliminary results indicate that YGJM formula can ameliorate NASH mechanistically by interfering with PINK1/parkin-mediated mitophagy and NLRP3 inflammasome to exert anti-inflammation ability and promote mitochondrial function restoration.

摘要

作为一种有效的中药方剂,羊肝健胃丸(YGJM)在改善非酒精性脂肪性肝炎(NASH)的肝损伤和肝脂肪变性方面表现出独特的优势。然而,其相关的药理机制仍需阐明。本研究旨在探讨 YGJM 方通过 PINK1/parkin 信号通路和 NOD 样受体蛋白 3(NLRP3)炎性小体对 NASH 中自噬的分子机制。高脂饮食大鼠和游离脂肪酸诱导的 HepG2 细胞被用作 NASH 模型。采用肝组织病理学和血清肝功能指标(天冬氨酸转移酶、丙氨酸转移酶、甘油三酯和总胆固醇)评估肝损伤和脂质堆积程度。此外,通过透射电镜、JC-1 和 2',7'-二氯荧光素二乙酸酯观察肝线粒体形态以及细胞线粒体膜电位和活性氧水平。此外,通过免疫组织化学、免疫荧光、RT-PCR(逆转录-聚合酶链反应)和 Western blot 检测 PINK1/parkin 介导的自噬和 NLRP3 炎性小体的表达,以阐明 YGJM 方的作用机制。病理和生化检测结果表明,YGJM 方具有缓解肝损伤和脂质沉积的作用。同时,YGJM 方能明显改善线粒体功能。此外,YGJM 方表现出促进 PINK1/parkin 介导的自噬,从而扰乱 NLRP3 炎性小体的激活,进而抑制肝细胞炎症。我们的初步结果表明,YGJM 方通过干扰 PINK1/parkin 介导的自噬和 NLRP3 炎性小体来改善 NASH,从而发挥抗炎作用并促进线粒体功能恢复。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验